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INTRODUCTION
Achalasia is an esophageal 
motility disorder characterised 
by aperistalsis of the esophageal 
body and impaired function of 
the lower esophageal sphincter 
(LES) [1, 2]. It is a rare condition, 
with an incidence rate of 
1.63/100 000 and a prevalence 
of 10.82/100 000 in the North 
American populat ion [3]. 
The first case of achalasia was 
reported in 1674 by Thomas 
Willis, who treated the patients 
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ABSTRACT
Background & Aim: Endoscopic balloon dilation (EBD) and laparoscopic Heller myotomy (LHM) are the 
most commonly performed treatment options for achalasia. Decision between these treatment options is 
difficult. The aim of this meta-analysis was to evaluate the efficacy of EBD compared to LHM.
Methods: The electronic databases PubMed, Embase and Cochrane Controlled Trials Registry were 
systematically searched for the period between January 1, 1976 and December 31, 2015. Meta-analysis was 
performed using the PICOS (problem, intervention, comparison, outcome, study design) format. Efficacy and 
safety of EBD were compared to LHM. Forest plot analyses were used to illustrate the success rate, perforation 
rate and post-procedural gastroesophageal reflux.
Results: Using the search strategy, eight studies met the selection criteria and were included in the meta-
analysis. The total number of patients included was 749 (360 in the EBD group and 389 in the LHM group). 
The success rate was lower in the EBD group than in the LHM group (OR=0.486; CI: 0.304-0.779; p=0.003). 
The rate of perforation did not differ significantly between the EBD and LHM group (RR= 0.635, CI: 0.340-
1.186, p=0.154). The incidence of post-procedural symptomatic gastroesophageal reflux did not differ between 
the two treatment groups (RR=0.663, CI: 0.328-1.343, p=0.254). 
Conclusion: Our data suggest that the efficacy of LHM is superior to that of EBD, while there is no difference 
in safety between the two treatment groups. 
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by using a whalebone [4, 5]. The pathophysiology of the 
motor abnormalities is not well understood. Histologic 
studies have demonstrated chronic inflammatory infiltration 
of the myenteric plexus (Auerbach’s). An initial injury results 
in myenteric plexus inflammation, which can lead to an 
autoimmune response [6]. As a result, esophageal aperistalsis 
develops with food retention in the lower esophagus, which 
causes the main symptoms. The typical symptoms of the 
patients with achalasia include dysphagia, regurgitation, 
weight loss, retrosternal chest pain and nocturnal coughing 
[7]. Therefore, treatment aims for achalasia include decreasing 
the pressure of the LES, ameliorating the esophageal emptying 
and preventing megaesophagus [5]. Pneumatic dilation and 
surgical myotomy are the most widely used treatment options 
for patients with achalasia. 
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Heller myotomy was first described in 1913 by Ernest Heller 
and has been used with only a few technical improvements. 
Laparoscopic management was added to the treatment options 
in 1991 [8]. Laparoscopic Heller myotomy (LHM) improves 
the symptoms of patients. The reported clinical success rate is 
89% (range 76-100%) [9]. The most common post-myotomy 
complication is gastro-esophageal reflux disease (GERD).   
Endoscopic balloon dilation (EBD) of the LES is the most 
effective non-surgical endoscopic treatment for achalasia [10]. 
Pneumatic dilation was the first attempt in the treatment of 
esophageal achalasia. The procedure tears the LES circular 
muscle fibers with an air-filled polyethylene balloon. Severe 
GERD is rare after pneumatic dilation. The most severe 
complication is perforation, which occurs in about 1-3% of 
the cases [5, 11], 50% of cases requiring surgery [12]. Over a 
5-10 year period the balloon dilation is the most cost-effective 
treatment for achalasia [13]. Decision between these treatment 
options is difficult to make due to the lack of large randomized 
controlled trials. Our meta-analysis was conducted to find out 
whether there is a clinically significant difference in efficacy and 
safety between EBD and LHM when applied for the treatment 
of esophageal achalasia in adult patients. The latest meta-
analysis on this topic (Schoenberg et al., 2013) [14] concluded 
that both the short and long-term efficacy of LHM is better. We 
used the PICOS (problem, intervention, comparison, outcome, 
study design) format for our study.
METHODS
Data sources 
Electronic databases, including PubMed, Cochrane 
Controlled Trials Registry and EMBASE were searched for 
studies published between January 1, 1976 and December 31, 
2015. To answer our clinical questions the PICOS approach 
was used, deciphered as P: achalasia, I: laparoscopic Heller 
myotomy, C: pneumatic dilation, O: remission, success, 
S: randomized and non-randomized, prospective and 
retrospective studies. The search strategy was achalasia AND 
Heller myotomy AND pneumatic dilation. We narrowed 
down the search focus to English language studies. The study 
was conducted following the Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA) guidelines. 
Study selection and data extraction
In the meta-analysis we included all randomized, non-
randomized, prospective and retrospective, original human, 
minimum 1-year-long-follow up studies on adult patients with 
primary achalasia reporting comparisons between EBD and 
LHM. An independent eligibility assessment was performed 
by each author, and disagreements were resolved by consensus. 
Duplicates, case reports, technical reports, reviews, editorials, 
abstracts were excluded. The following data were collected: 
type of study design, year of publication, number of patients, 
median/average patient age, gender distribution, post-
procedural success rate, intra- and post-procedural perforation 
rate and post-procedural symptomatic gastroesophageal reflux. 
Treatment efficacy was defined by the success rate in percentage 
at 1 year after therapy. The investigators extracted the data 
from each publication independently and two investigators 
then validated these data. Disagreements were discussed and 
resolved by consensus.  
Statistical analysis
Dichotomous outcome data from individual studies 
were extracted, from which risk ratios (RRs) or odds ratios 
(ORs) and 95% confidence intervals (CIs) were estimated by 
meta-analysis, using the Mantel–Haenszel method [15]. The 
Comprehensive MetaAnalysis (Version3) statistical software 
was used for the calculations. Heterogeneity was tested by using 
the Cochrane’s Q and the I2 statistics. In the Q-statistics p-value 
less than 0.05 was regarded as significant heterogeneity. The I2 
shows the proportion of total variation contributed by between-
study variability and an I2 value higher than 50 suggests a 
considerable heterogeneity [16]. Homogeneous results utilized 
the fixed effects model (Peto method) for statistical analysis. 
The random effects model (DerSimonian–Laird method) 
was employed for heterogeneous results and the data were 
presented using a Forest plot [17].
RESULTS
Characteristics of the studies included 
Using our search strategy, 176 publications were identified 
in the Embase, 142 were found in the PubMed database and 
1 in the Cochrane Library. Finally, 8 studies met the selection 
criteria and were included in the quantitative synthesis of this 
meta-analysis (Fig. 1). Six randomized studies and two non-
randomized studies were identified during our search. 
In our meta-analysis, we compared the data of 749 achalasia 
patients from 8 trials who were treated with either EBD or 
LHM. The analysis included 360 patients in the balloon dilation 
group and 389 in the Heller myotomy group. One study (Borges 
et al.) [18] reported significant differences in the patients’ ages 
between the two treatment groups, but in the other 7 studies 
no significant difference was found in this regard. The data 
published in 8 studies assessing the distribution of genders 
showed no difference between the two groups. Six of the 8 
studies were single center trials while the remaining 2 were 
multi-centric. Table I shows the original data of the 8 studies 
included in our analysis. 
Quality of the included studies
A Cochrane risk of bias assessment was applied to all 
studies. Risk of bias assessment included random sequence 
generation, allocation concealment, blinding of participants 
and personnel, blinding of outcome assessment, incomplete 
outcome data addressed and selective reporting. All trials were 
open, not blinded for participants and personnel. One study 
was blinded for outcome assessment while the remaining seven 
had high risk of performance and detection bias.  Six studies 
were randomized and four reported allocation concealment. 
All of the included studies avoided selection bias. Six studies 
addressed incomplete outcome data and had low risk of 
attrition bias and the remaining two were unclear in this aspect 
(Supplementary Table I).
Funnel plot asymmetry was used to detect publication bias. 
Asymmetry was not confirmed regarding success rate, while it 
was detected in cases of reflux and perforation  (Suppl. Figs. 1-3). 
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Meta-analysis of short-term efficacy and safety
Success rate 
Perioperative symptom assessment was similar in two 
studies, Moonen et al. [19] and Boeckxstaens et al. [20]: the 
primary outcome of these studies was therapeutic success (a 
reduction in the Eckardt score to ≤3). Two other studies [21, 
22] also used Eckardt score to evaluate the therapeutic success. 
Clinical remission was reported when the patient was totally 
asymptomatic or the Eckardt score decreased by at least 2 
points and did not exceed 3 points in the study of Wang et al. 
[21]. Tabola et al. [22] applied symptom improvement rate by 
reduction of the Eckardt score and evaluated the frequency of 
reintervention. In the other 4 studies, symptom evaluation was 
based on various dysphagia scores. In the Hamdy et al. study 
Fig. 1. Organogram of article search in the PubMed, EMBASE and Cochrane 
databases.
Table I. Original data collected from the eight articles.
Type of therapy Number of 
patients
Success rate  
12 month (%)
Perforation 
rate (%)
Reflux 
rate (%)
Wang et al. 2015 [21] Balloon dilation 21 81.0 0.0 19.0 
Heller myotomy 21 91.5 0.0 52.4 
Moonen at al. 2015 [19] Balloon dilation 96 90.0 5.0 12.0 
Heller myotomy 105 93.9 12.0 34.0 
Tabola et al. 2013 [22] Balloon dilation 21 81.0 4.8 No information
Heller myotomy 38 92.1 5.2 
Borges et al. 2014 [18] Balloon dilation 48 63.6 4.0 27.7 
Heller myotomy 44 69.0 0.0 4.7 
Persson et al. 2015 [24] Balloon dilation 28 79.0 7.14 No information
Heller myotomy 25 96.0 0.0 
Hamdy et al. 2015 [23] Balloon dilation 25 56.0 8.0 16.0 
Heller myotomy 25 96.0 4.0 28.0 
Boeckxstaens et al. 2011 [20] Balloon dilation 95 90.0 4.0 15.0 
Heller myotomy 106 93.0 12.0 23.0 
Kostic et al. 2007 [25] Balloon dilation 26 76.9 % 
(not failure)
8.0 No information
Heller myotomy 25 96 0.0 
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[23], the primary outcome was the successful symptomatic 
improvement, which used Demeester’s grading of dysphagia. 
In two other studies [24, 25], the primary end point was the 
cumulative number of treatment failures (incomplete symptom 
control, symptom relapse, serious complication, required re-
intervention) and the dysphagia was assessed with the Watson 
dysphagia score. The major outcome of the study of Borges 
et al. [18] was the clinical improvement of the Vantrappen 
and Hellemans dysphagia score. Good responders mean 
excellent results (asymptomatic) or good results (dysphagia 
less than once a week, no weight loss or food regurgitation). 
All studies reported their success rate at 1-year of the follow 
up: the success rate was significantly lower in the EBD group 
than in the LHM group (OR: 0.486; CI: 0.304-0.779; p=0.003). 
Significant heterogeneity was observed among the included 
studies (Q=8.538 p=0.28; I²=97.993), therefore, the random-
effect model was used (Fig. 2).
Post-procedural symptomatic gastroesophageal reflux
In the Heller myotomy arm, all patients underwent an 
antireflux procedure, 4 studies reported anterior (Dor), 2 
studies posterior (Toupet) fundoplication and 2 studies 
reported partial fundoplication without accurate description. 
Five studies reported the incidence of post-procedural 
symptomatic GERD, which was investigated by reflux symptom 
or DeMeester score at pH testing. The outcome showed no 
significant difference between EBD and LHM (RR=0.663, CI: 
0.328-1.343, p=0.254) (Fig. 3). Since significant heterogeneity 
existed among the included studies, the random-effect model 
was used (Q=13.502, p=9.06, I²=70.376).
Perforation
Perforation was the most severe complication of EBD 
or LHM. Seven studies reported acceptable data regarding 
the perioperative perforation rate. Our meta-analysis of 
perforation did not show any significant difference between 
perforation rates in the EBD and LHM groups (RR= 0.635, 
CI: 0.340-1.186, p=0.154) (Fig. 4). In this case, no significant 
heterogeneity could be detected between the studies, thus we 
used the fixed-effect model (Q=7.973, p=0.240, I²=24.754).
DISCUSSION
Achalasia is a motility disorder of the esophagus 
characterized by degenerative changes of the myenteric plexus, 
which lead to a selective loss of inhibitory nerve endings [4]. The 
Fig. 2. Forest plot of success rate. The odds ratio (OR) and 95 % confidence interval (CI) 
was calculated and shows the success of dilation versus myotomy. PD: pneumatic dilation; 
LM: laparaoscopic myotomy.
Fig. 3. Forest plot of risk ratio (RR) and CI for post-procedural reflux evaluation. PD: 
pneumatic dilation; LM: laparaoscopic myotomy.
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goals of the treatment for achalasia are to decrease the pressure 
of the LES, ameliorate the esophageal emptying and prevent the 
occurence of megaesophagus [5]. Various therapeutic facilities 
are available. The most preferred therapeutic approaches 
are EBD and LHM, but a very promising new technique is 
the peroral endoscopic myotomy (POEM), a less invasive 
endoscopic treatment for esophageal achalasia [26]. While 
POEM seems to be a very promising technique, the availability 
of this endoscopic technique is still limited. On the other hand, 
EBD and LHM are both effectively and regularly used to treat 
achalasia. Decision between these treatment options is difficult. 
Pneumatic dilation is a simple and safe procedure: the 
results of studies on the topic show that EBD is effective, with 
response rates ranging from 40% to 78% within 5 years and 
from 12% to 58% within 15 years [27, 28]. The major predictive 
factors for the failure of EBD treatment include young age (age 
< 40 years) [1, 29], male gender, dilation by using a 30-mm 
balloon, presence of pulmonary symptoms, failure of treatment 
after one or two dilation sessions [27, 30]. However, EBD is 
the most cost-effective treatment for achalasia for a period of 
5 to 10 years after the procedures [13, 31]. The most serious 
complication is perforation, which occurred in about 1-3% of 
the cases [5, 11], and 50% of those patients required surgical 
intervention [12]. Other complications following pneumatic 
dilation are usually minor (mucosal tear, fever, bleeding, chest 
pain) [32].
When using LHM, an improvement of symptoms was 
recorded in 89% of patients (range 77–100%) after a systematic 
review of 39 uncontrolled studies on laparoscopic myotomy 
[9]. However, the success rates after 5 years decreased to 
65-85%, possibly as a result of disease progression [33]. 
Gastro-esophageal reflux disease is a frequent complication 
following myotomy. The combination of myotomy with a 
partial fundoplication decreases, but does not completely 
eliminate the risk of GERD. Recently published guidelines 
from both gastroenterology and surgical societies recommend 
an antireflux procedure along with myotomy [10, 34]. A 
prospective randomized trial [35] evidenced a pathological 
GERD rate of 47.6 % in the group with Heller myotomy without 
antireflux procedure compared to a 9.1% in the group with 
Heller myotomy followed by anterior fundoplication.
Laparoscopic Heller myotomy with partial fundoplication 
is a very safe operation with a mortality rate of 0.1%  [36]. 
The most common complication of LHM is perforation of 
esophagus or stomach with an average rate of 6.3% during the 
myotomy, which can be usually repaired without severe clinical 
consequences [37]. Recurrence of dysphagia usually develops 
within 12-18 months following LHM [38].
At present, EBD and LHM are the most effective treatment 
options for achalasia. When comparing the effect of LHM 
with EBD, most authors conclude that LHM is superior to 
pneumatic dilation with respect to clinical remission, relapse 
rate and safety. The latest meta-analysis [14] showed that 
myotomy has a higher short- and long-term efficacy. The goal 
of our research was to summarize the results of the treatment 
options for achalasia. The present meta-analysis involved 8 
studies comparing EBD with LHM in 749 achalasia patients. 
The findings indicate that EBD and LHM are similar in terms 
of the incidence of perforation and post-procedural reflux 
disease, while regarding the success rate at 1-year follow up 
EBD evidences worse results compared to those of LHM. 
Evaluation of the therapeutic success was variable in the 
analysed studies. In the studies by Boeckxstaens et al. [20], 
Moonen et al. [19], Wang et al. [21], Tabola et al. [22], the authors 
used the Eckardt score to assess the success rate, while Tabola et 
al. applied the symptom improvement rate by reduction of the 
Eckardt score and by evaluating the frequency of reintervention. 
In 4 other studies, symptom evaluation was based on various 
dysphagia scores. In the studies by Hamdy et al. [23] and Borges 
et al. [18] the primary outcome was the successful symptomatic 
improvement, which used the Demeester’s or Vantrappen and 
Hellemans dysphagia score. In the studies by Persson et al. [24] 
and Kostic et al. [25] the primary end point was the cumulative 
number of treatment failures. Six of the eight studies included 
in the analysis found LHM more effective than EBD, while the 
remaining two studies showed similar results for both techniques 
within a follow-up period. The two studies [19, 20] which 
demonstrate that EBD and LHM are similar in effectiveness are 
large multicenter randomized trials involving many patients. The 
other six studies are small trials with a smaller sample size. We 
identified six randomized and two non-randomized studies. The 
two non-randomized studies [21, 22] found the same results as 
Fig. 4. Forest plot of  risk ratio (RR) and CI for the perforation rate. PD: pneumatic 
dilation; LM: laparaoscopic myotomy; perf.: perforation.
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the other four randomized small trials. We assume that the study 
type did not affect the results, but the number of patients and the 
duration of follow-up period may have influenced the outcomes. 
Our meta-analysis has some limitations. Heterogeneity in 
the follow-up period and the various criteria of therapeutic 
success among different centres certainly represented the weak 
points of all included studies.
Previous studies also examined post-procedural 
complications. Our results showed that the perforation rate 
did not differ between the EBD and LHM groups. Wang et al. 
[21] did not observe perforation in either group, four studies 
demonstrated a lower perforation rate in the LHM group 
than in the EBD group, while other three studies showed 
lower perforation rate in the EBD group. Such contradictions 
are presumably due to the heterogeneity of centres and 
various expertise levels of the endoscopists and surgeons in 
different centers. Perforation is a significant complication, and 
therefore the procedure should be performed with care and by 
experienced endoscopists or surgeons. In our analysis, there was 
no significant difference between EBD and LHM regarding the 
evaluation of post-procedural GERD. Many previous studies 
found that GERD was more frequent in the LHM group than 
in the EBD group. Among the trials included in our meta-
analysis, five studies reported symptomatic post-procedural 
GERD occurrence and four studies found that GERD developed 
more frequently in the LHM group. Our statistical analysis did 
not reveal significant differences, but we observed a trend for 
a higher occurrence rate of GERD after LHM than after EBD. 
CONCLUSION
This meta-analysis suggests that the effectiveness of LHM 
is superior to EBD and a better success rate can be obtained 
after myotomy. There was no difference in the perforation 
rate and post-procedural GERD evaluation between the two 
treatment options. Further large, randomized, controlled trials 
are required to compare LHM and pneumatic dilation. 
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Supplementary Table I. Characteristics of studies included meta-analysis. Key: +: low risk of bias, –: 
high risk of bias, ?: unclear risk of bias 
 
 Random 
sequence 
generation 
(selection bias) 
Study design Blinding of 
participants 
and 
personnel 
(performance 
bias) 
Allocation 
concealment 
(selection 
bias) 
Incomplete 
outcome data 
addressed 
(attrition 
bias) 
Blinding of 
outcome 
assessment 
(detection 
bias) 
Selective 
reporting 
(reporting 
bias) 
Wang et al. 
2015 (21) Non-randomized  retrospective – – ? – + 
Moonen at al. 
2015 (19) Randomized  prospective – + + – + 
Tabola et al. 
2013 (22) Non-randomized  prospective – – + – + 
Borges et al. 
2014 (18) Randomized  prospective    – ? + – + 
Persson et al. 
2015 (24) Randomized  prospective – + + + + 
Hamdy et al. 
2015 (23) Randomized  prospective – + ? – + 
Boeckxstaens et 
al. 2011 (20) Randomized  prospective – + + – + 
Kostic et al. 
2007 (25) Randomized  prospective – ? + – + 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Fig. 1.Funnel plot of studies evaluating success rate in balloon dilation and 
 Heller myotomy groups. Visual inspection did not show asymmetry.  
  
 
 
Supplementary Fig. 2.  Funnel plot of studies evaluating post-procedural reflux in balloon dilation 
and Heller myotomy groups.  Asymmetry is observed visually. In study by Borges et al. fell outside. 
 
 
 
 
 
 
 
Supplementary Fig. 3. Funnel plot of studies evaluating perforation rate in balloon dilation and 
Heller myotomy groups.  Asymmetry is observed visually. 
